TY - JOUR
T1 - CoO Nanozymes with Multiple Catalytic Activities Regulate Atopic Dermatitis
AU - Mao, Mao
AU - Guan, Xuejiao
AU - Wu, Feng
AU - Ma, Lan
N1 - Funding Information:
Funding: This research was funded by the National Key R&D Plan in China (2020YFA0908900), State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2/14
Y1 - 2022/2/14
N2 - Herein, we prepared CoO nanozymes with three types of enzyme catalytic activities for the first time, which have SOD-like, CAT-like, and POD-like catalytic activities. This is the first study to report the preparation of CoO nanoparticles with three types of enzyme catalytic activities by the one-pot method. By modifying the surface of CoO nanozymes with a carboxyl group, its biocompatibility enhanced, so it can be used in the field of life sciences. In vitro cytotoxicity and anti-H2 O2-induced ROS experiments proved that CoO nanozymes can protect HaCaT cells against ROS and cytotoxicity induced by H2 O2 . In addition, an atopic dermatitis (AD) mouse model was established by topical application of MC903, which verified the anti-inflammatory effect of CoO nanozymes on the AD mouse model. Traditional drugs for the treatment of AD, such as dexamethasone, have significant side-effects. The side-effects include skin burns, telangiectasias, and even serious drug dependence. CoO nano-enzymes have a low cytotoxicity and its multiple enzyme-like catalytic activities can effectively protect cells and tissues in ROS environments, which proves that CoO nano-enzymes have high application potential in the field of anti-inflammation.
AB - Herein, we prepared CoO nanozymes with three types of enzyme catalytic activities for the first time, which have SOD-like, CAT-like, and POD-like catalytic activities. This is the first study to report the preparation of CoO nanoparticles with three types of enzyme catalytic activities by the one-pot method. By modifying the surface of CoO nanozymes with a carboxyl group, its biocompatibility enhanced, so it can be used in the field of life sciences. In vitro cytotoxicity and anti-H2 O2-induced ROS experiments proved that CoO nanozymes can protect HaCaT cells against ROS and cytotoxicity induced by H2 O2 . In addition, an atopic dermatitis (AD) mouse model was established by topical application of MC903, which verified the anti-inflammatory effect of CoO nanozymes on the AD mouse model. Traditional drugs for the treatment of AD, such as dexamethasone, have significant side-effects. The side-effects include skin burns, telangiectasias, and even serious drug dependence. CoO nano-enzymes have a low cytotoxicity and its multiple enzyme-like catalytic activities can effectively protect cells and tissues in ROS environments, which proves that CoO nano-enzymes have high application potential in the field of anti-inflammation.
KW - Atopic dermatitis
KW - CoO
KW - Enzyme-like catalytic activity
KW - Nanozyme
UR - http://www.scopus.com/inward/record.url?scp=85124397471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124397471&partnerID=8YFLogxK
U2 - 10.3390/nano12040638
DO - 10.3390/nano12040638
M3 - Article
C2 - 35214972
AN - SCOPUS:85124397471
SN - 2079-4991
VL - 12
JO - Nanomaterials
JF - Nanomaterials
IS - 4
M1 - 638
ER -